These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32048900)

  • 1. Comparison of the efficacy of Tacrolimus 0.1% ointment and Tacrolimus 0.1% plus topical pseudocatalase/superoxide dismutase gel in children with limited vitiligo: a randomized controlled trial.
    Alshiyab DM; Al-Qarqaz FA; Muhaidat JM; Alkhader YS; Al-Sheyab RF; Jafaar SI
    J Dermatolog Treat; 2022 Feb; 33(1):146-149. PubMed ID: 32048900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series.
    Tanghetti EA
    Cutis; 2003 Feb; 71(2):158-62. PubMed ID: 12635898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
    Majid I
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Childhood Vitiligo Using Tacrolimus Ointment with Narrowband Ultraviolet B Phototherapy.
    Dayal S; Sahu P; Gupta N
    Pediatr Dermatol; 2016 Nov; 33(6):646-651. PubMed ID: 27699846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical tacrolimus for treatment of childhood vitiligo in Asians.
    Kanwar AJ; Dogra S; Parsad D
    Clin Exp Dermatol; 2004 Nov; 29(6):589-92. PubMed ID: 15550128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study.
    Hartmann A; Bröcker EB; Hamm H
    Acta Derm Venereol; 2008; 88(5):474-9. PubMed ID: 18779885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical tacrolimus for repigmentation of vitiligo.
    Grimes PE; Soriano T; Dytoc MT
    J Am Acad Dermatol; 2002 Nov; 47(5):789-91. PubMed ID: 12399778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
    Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases.
    Silverberg NB; Lin P; Travis L; Farley-Li J; Mancini AJ; Wagner AM; Chamlin SL; Paller AS
    J Am Acad Dermatol; 2004 Nov; 51(5):760-6. PubMed ID: 15523355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial.
    Alshiyab D; Ba-Shammakh SA; Al-Fakih A; Tashman O; Sarakbi D; Al-Qarqaz F; Muhaidat J; Atwan A; Cork MJ
    J Dermatolog Treat; 2024 Dec; 35(1):2296851. PubMed ID: 38124534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study.
    Nordal EJ; Guleng GE; Rönnevig JR
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1440-3. PubMed ID: 21466589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review.
    Sisti A; Sisti G; Oranges CM
    An Bras Dermatol; 2016 Apr; 91(2):187-95. PubMed ID: 27192518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical Tacrolimus Ointment Alone versus in Combination with Microneedling for Refractory Stable Vitiligo.
    Kiran A; Khan S; Ahmed N; Ali M
    J Coll Physicians Surg Pak; 2024 May; 34(5):514-517. PubMed ID: 38720208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
    Fai D; Cassano N; Vena GA
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdermabrasion and topical tacrolimus: A novel combination therapy of vitiligo.
    Abd-Elazim NE; Yassa HA; Mahran AM
    J Cosmet Dermatol; 2020 Jun; 19(6):1447-1455. PubMed ID: 31668003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo.
    Ho N; Pope E; Weinstein M; Greenberg S; Webster C; Krafchik BR
    Br J Dermatol; 2011 Sep; 165(3):626-32. PubMed ID: 21457214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo, NB-UVB and tacrolimus: our experience in Naples.
    Baldo A; Lodi G; Di Caterino P; Monfrecola G
    G Ital Dermatol Venereol; 2014 Feb; 149(1):123-30. PubMed ID: 24566573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo.
    Lan CC; Chen GS; Chiou MH; Wu CS; Chang CH; Yu HS
    Br J Dermatol; 2005 Sep; 153(3):498-505. PubMed ID: 16120133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized prospective study to assess the role of topical tacrolimus as preventive therapy in unstable acral vitiligo.
    Kumar D; Thakur V; Subburaj K; Bishnoi A; Vinay K; Sendhil Kumaran M; Parsad D
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2243-2248. PubMed ID: 37467136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus Tacrolimus 0.1% ointment versus Tacrolimus 0.1% ointment in the treatment of stable vitiligo.
    Shah B; Godse K; Mahajan S; Grandhi S; Shendkar S; Sharma A; Teli C; Pathak R; Parsad D
    Dermatol Ther; 2019 Nov; 32(6):e13109. PubMed ID: 31600833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.